Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
de Unamuno Bustos B, Murria Estal R, Pérez Simó G, de Juan Jimenez I, Escutia Muñoz B, Rodríguez Serna M, Alegre de Miquel V, Llavador Ros M, Ballester Sánchez R, Nagore Enguídanos E, Palanca Suela S, Botella Estrada R. de Unamuno Bustos B, et al. Among authors: de juan jimenez i. Sci Rep. 2017 Mar 29;7(1):495. doi: 10.1038/s41598-017-00606-w. Sci Rep. 2017. PMID: 28356599 Free PMC article.
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.
Murria Estal R, Palanca Suela S, de Juan Jiménez I, Alenda Gonzalez C, Egoavil Rojas C, García-Casado Z, López Guerrero JA, Juan Fita MJ, Sánchez Heras AB, Segura Huerta Á, Santaballa Bertrán A, Chirivella González I, Llop García M, Pérez Simó G, Barragán González E, Bolufer Gilabert P. Murria Estal R, et al. Among authors: de juan jimenez i. Fam Cancer. 2016 Apr;15(2):193-200. doi: 10.1007/s10689-015-9864-2. Fam Cancer. 2016. PMID: 26723934
MicroRNA signatures in hereditary breast cancer.
Murria Estal R, Palanca Suela S, de Juan Jiménez I, Egoavil Rojas C, García-Casado Z, Juan Fita MJ, Sánchez Heras AB, Segura Huerta A, Chirivella González I, Sánchez-Izquierdo D, Llop García M, Barragán González E, Bolufer Gilabert P. Murria Estal R, et al. Among authors: de juan jimenez i. Breast Cancer Res Treat. 2013 Nov;142(1):19-30. doi: 10.1007/s10549-013-2723-7. Epub 2013 Oct 16. Breast Cancer Res Treat. 2013. PMID: 24129975
Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population.
de Juan Jiménez I, Esteban Cardeñosa E, Palanca Suela S, Barragán González E, Aznar Carretero I, Munárriz Gandía B, Santaballa Bertran A, Torregrosa Maicas MD, Guillén Ponce C, Sánchez Heras AB, Bayón Lara A, Fuster Lluch O, Bolufer Gilabert P. de Juan Jiménez I, et al. Fam Cancer. 2012 Mar;11(1):49-56. doi: 10.1007/s10689-011-9481-7. Fam Cancer. 2012. PMID: 21918853
Low penetrance alleles as risk modifiers in familial and sporadic breast cancer.
Esteban Cardeñosa E, de Juan Jiménez I, Palanca Suela S, Chirivella González I, Segura Huerta A, Santaballa Beltran A, Casals El Busto M, Barragán González E, Fuster Lluch O, Bermúdez Edo J, Bolufer Gilabert P. Esteban Cardeñosa E, et al. Among authors: de juan jimenez i. Fam Cancer. 2012 Dec;11(4):629-36. doi: 10.1007/s10689-012-9563-1. Fam Cancer. 2012. PMID: 22926736
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
Palanca Suela S, Esteban Cardeñosa E, Barragán González E, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Montalar Salcedo J, Castel Sánchez V, Bolufer Gilabert P; Group for Assessment of Hereditary Cancer of Valencia Community. Palanca Suela S, et al. Among authors: de juan jimenez i. Breast Cancer Res Treat. 2010 Jan;119(1):87-93. doi: 10.1007/s10549-009-0316-2. Epub 2009 Feb 12. Breast Cancer Res Treat. 2010. PMID: 19214744
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
de Juan Jiménez I, García Casado Z, Palanca Suela S, Esteban Cardeñosa E, López Guerrero JA, Segura Huerta Á, Chirivella González I, Sánchez Heras AB, Juan Fita MJ, Tena García I, Guillen Ponce C, Martínez de Dueñas E, Romero Noguera I, Salas Trejo D, Goicoechea Sáez M, Bolufer Gilabert P. de Juan Jiménez I, et al. Fam Cancer. 2013 Dec;12(4):767-77. doi: 10.1007/s10689-013-9622-2. Fam Cancer. 2013. PMID: 23479189
Relationship of BRCA1 and BRCA2 mutations with cancer burden in the family and tumor incidence.
Esteban Cardeñosa E, Bolufer Gilabert P, de Juan Jiménez I, Palanca Suela S, Barragán González E, González Anguix V, Lerma Alejos E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Cuevas Cuerda D, Salas Trejo D; Group for Assessment for Hereditary Cancer of Valencian Community. Esteban Cardeñosa E, et al. Among authors: de juan jimenez i. Fam Cancer. 2010 Sep;9(3):291-5. doi: 10.1007/s10689-010-9327-8. Fam Cancer. 2010. PMID: 20711702
Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.
Esteban Cardeñosa E, Bolufer Gilabert P, de Juan Jimenez I, Palanca Suela S, Barragán González E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E. Esteban Cardeñosa E, et al. Among authors: de juan jimenez i. Breast Cancer Res Treat. 2010 May;121(1):257-60. doi: 10.1007/s10549-009-0680-y. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033483 No abstract available.
12 results